NCT02730299 Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS Status COMPLETED Phase PHASE3
NCT02722668 UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep Status COMPLETED Phase PHASE2
NCT02693899 Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia Status COMPLETED Phase N/A
NCT02677064 Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia Status RECRUITING Phase N/A
NCT02580071 Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients Status COMPLETED Phase NA
NCT02487069 Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy Status COMPLETED Phase NA
NCT02445378 Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy Status COMPLETED Phase NA
NCT02440178 Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia Status COMPLETED Phase PHASE2
NCT02356159 Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT02353559 Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia Status COMPLETED Phase NA
NCT02345850 Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) Status COMPLETED Phase PHASE3
NCT02344966 Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia Status UNKNOWN Phase N/A
NCT02344953 Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort) Status UNKNOWN Phase N/A
NCT02320656 Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015 Status COMPLETED Phase NA
NCT02208037 Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Status COMPLETED Phase PHASE2
NCT02169791 Nonmyeloablative Haploidentical Transplant Followed by MLN9708 Status COMPLETED Phase PHASE2
NCT02038361 Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome and Transcriptome by Micro-array Status COMPLETED Phase NA
NCT01956630 Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT Status UNKNOWN Phase PHASE1/PHASE2